TrialReader


Accuro XV Ultrasound Imaging System for BoneEnhance and Fracture Detection Algorithms

NCT07853768 — Not applicable, Recruiting, 25000 participants, Rivanna Medical, Inc.

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

MSK Injury Assessment Imaging System: Feasibility and Data Acquisition for Algorithm Development and Testing

RegistryNCT07853768
StatusRecruiting
PhaseNot applicable
Study typeInterventional; na, single group, masking: none, other
Enrollment25000 (Estimated)
SponsorRivanna Medical, Inc. (Industry)
ConditionsFracture Arm, Fracture Leg, Wrist Injury, Ankle Injury
InterventionsAccuro XV Ultrasound Imaging System (Device)
Datesstart 2024-01-29, primary completion 2027-08-01 (estimated), completion 2027-08-01 (estimated), first posted 2026-10-02, last updated 2026-10-15
Locations10 sites in United States

Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for Fracture Arm All trials for Fracture Leg All trials of Accuro XV Ultrasound Imaging System

-Summary

The Accuro XV is a cart-based, bedside ultrasound instrument that incorporates new signal processing-based technologies for enhanced bone and soft-tissue imaging.

Patients presenting to the Study Setting (e.g., Emergency Departments, urgent care centers, orthopedic clinics, radiology departments, and other clinical environments with access to standard-of-care (SOC) imaging with a suspected distal extremity injury (wrist, forearm, ankle, or lower leg) who have undergone SOC imaging during their clinical evaluation, will be enrolled for additional extremity imaging with the Accuro XV.

In this feasibility study, investigators will assess the safety of Accuro XV by review of any adverse events (AEs) and by comparing the comfort level of patients during Accuro XV image capture and standard-of-care imaging. Investigators will retrospectively assess image quality by reviewing all images captured to ensure the image is clear of artifact and other visual imperfections. The de-identified imaging data will then be used for algorithm development and testing. This data will help to verify plans for future study protocols and help to ensure the device is optimized for its clinical use prior to further clinical studies. The results will also be used as an input to RIVANNA's usability and human factors engineering process per IEC 60601-1-6 as recognized by FDA.

The Accuro XV is investigational in this study and is not intended to guide clinical decision-making.

Expand all sections  ·  Collapse all

+Arms and interventions

ArmTypeInterventionsDescription
Accuro XV ImagingExperimentalDevice: Accuro XV Ultrasound Imaging SystemParticipants with a distal extremity injury who have undergone standard-of-care imaging will receive additional imaging with the Accuro XV ultrasound imaging system. Accuro XV imaging will be performed after completion of standard-of-care clinical imaging and will not be used for clinical decision-making or patient management. Imaging data collected during the study will be used to evaluate device feasibility, safety, image quality, and to support the development and testing of future algorithms.
  • Accuro XV Ultrasound Imaging System (Device): The Accuro XV Ultrasound Imaging System is a cart-based ultrasound imaging device designed to acquire volumetric images of bone and soft tissue anatomy of the distal extremities. In this study, participants will undergo additional Accuro XV imaging following standard-of-care imaging for a distal extremity injury. The imaging procedure includes acquisition of multiple views of the injured anatomy using ultrasound technology and advanced image-processing methods to generate three-dimensional representations of bone and soft tissue structures. Images collected during the study will be used to evaluate device feasibility, safety, image quality, and to support the development and testing of future algorithms. Accuro XV imaging results will not be used for clinical decision-making.

+Outcome measures

Primary outcomes

  • Accuro XV Image Quality Assessment [From Accuro XV image acquisition through completion of retrospective image-quality assessment, up to 48 months.]: Retrospective assessment of acquired Accuro XV images for artifacts and other visual imperfections to evaluate image quality and suitability for subsequent analysis and algorithm development.
  • Feasibility of Accuro XV Imaging Acquisition [During and immediately after Accuro XV imaging on the day of enrollment.]: Successful acquisition of Accuro XV images of the target distal extremity anatomy according to study procedures; site PIs, AIs, and other Accuro XV users will be queried on how Accuro XV fits into their clinical workflow in terms of usability, maneuverablity, reliability and more. Surveys to be developed.
  • Participant Comfort During Imaging [Immediately after Accuro XV imaging on the day of enrollment.]: Participant-reported comfort and pain scores associated with Accuro XV imaging collected through the participant questionnaire. Participants completed a questionnaire assessing pain associated with both standard-of-care imaging and Accuro XV scanning. Specifically, participants were asked to rate their pain (1) before standard-of-care imaging, (2) during standard-of-care imaging, (3) before Accuro XV scans, and (4) during Accuro XV scans. Pain was measured using an 11-point Likert-type scale ranging from 0 ("none") to 10 ("severe"), with higher scores indicating greater pain.

Secondary outcomes

  • Likert-Type Scale Participant-reported Imaging Modality Preference [Immediately after Accuro XV imaging on the day of enrollment.]: Participant-reported preference between Accuro XV imaging and standard-of-care imaging modalities. Participants completed a questionnaire assessing satisfaction with both standard-of-care imaging and Accuro XV scanning. Participants were asked to rate their satisfaction with each imaging modality on an 11-point Likert-type scale ranging from 0 ("not satisfied at all") to 10 ("very satisfied"), with higher scores indicating greater satisfaction. In addition, participants were asked to indicate their preferred imaging modality by selecting either Accuro XV, standard-of-care imaging, or no preference.

+Eligibility

Sex: All, ages: 5 Years to any

Sites are currently on two different protocol Revisions.

Inclusion Criteria

* Age greater than or equal to 5 years.
* The patient is presenting for distal limb injury of the wrist, forearm, ankle, or lower leg.
* The patient is scheduled to receive an X-ray that includes a view of the ankle, lower leg, wrist, and/or forearm or any patient that received an X-ray accessible by the study team for the studied anatomy in the past 48 hours.
* English and/or Spanish speaking.

Exclusion Criteria

* An open fracture, grossly open wound, or severe angulation of the limb is present.
* Patients for whom the site investigator feels that study participation could prohibit or impair ongoing medical care.
* Known allergy to ultrasound couplants.

+Locations (10)

FacilityCityCountryStatus
The University of California San FranciscoSan Francisco, CaliforniaUnited StatesRecruiting
The University of Colorado DenverDenver, ColoradoUnited StatesRecruiting
Yale UniversityNew Haven, ConnecticutUnited StatesRecruiting
Rush University Medical CenterChicago, IllinoisUnited StatesRecruiting
Thomas Jefferson University HospitalPhiladelphia, PennsylvaniaUnited StatesRecruiting
The University of Texas SouthwesternDallas, TexasUnited StatesRecruiting
Texas Tech University Health Sciences CenterEl Paso, TexasUnited StatesRecruiting
The University of UtahSalt Lake City, UtahUnited StatesRecruiting
The University of VirginiaCharlottesville, VirginiaUnited StatesRecruiting
Virginia Commonwealth UniversityRichmond, VirginiaUnited StatesRecruiting

My Notes